GLP-1s, Fertility & Birth Control

10 min read
Weight Loss
Last Updated: Nov 20, 2026
Woman journaling at home in morning light for an article about GLP-1s, fertility, and birth control.

GLP-1 medications may affect fertility and birth control. Learn what the research says about "Ozempic® babies" & pregnancy safety. Consult a provider today.

Key takeaways
  • When it comes to GLP-1 and fertility, most improvements appear to come from weight loss helping ovulation return, not from the medications acting as fertility drugs.
  • Women with PCOS may see the greatest fertility-related benefit, since most research on GLP-1 and fertility has been done in this group.
  • Tirzepatide may make birth control pills less effective for 4 weeks after starting and after each dose increase; this is why the brand-name labels advise a non-oral or backup method during those windows.
  • If you take compounded tirzepatide or follow a lower-dose plan, ask your provider whether the same precaution applies each time your dose increases.
  • GLP-1s should be stopped as soon as pregnancy is recognized and ahead of a planned pregnancy, regardless of dose.
  • These medications aren't approved fertility treatments; this means that any decision about GLP-1 use, contraception, and pregnancy planning should be made with a licensed healthcare provider. This article is intended for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always talk with a licensed healthcare provider before starting, changing, or stopping any medication, including birth control. GLP-1 medications are not approved for fertility treatment or for use during pregnancy.

Compounded medications are not FDA-approved. They are prepared by state-licensed pharmacies for individual patients when prescribed based on a licensed provider's determination of a clinically significant difference for an identified patient. They are not reviewed by the FDA for safety, effectiveness, or quality.

Jump to a section

Lately, social media has been filled with surprise pregnancy stories from women taking GLP-1 medications. Some have been trying for years. Others weren't trying at all. This trend has even earned a nickname: the Ozempic® baby boom.

So, what is the link between GLP-1 and fertility? Can GLP-1s improve fertility? Do they affect birth control? And what should you do if you're pregnant or planning to conceive while on one?

The information below applies to semaglutide and tirzepatide, whether brand-name or compounded. Keep in mind that no GLP-1 is approved to treat infertility, and decisions about pregnancy, birth control, and your medication should always involve a licensed healthcare provider. With that said, let's take a closer look.

‍

What Are "Ozempic® Babies," and Is the Trend Real?

"Ozempic® babies" is an informal term for unplanned pregnancies reported among individuals taking GLP-1 medications. The name points to one brand, but it's become shorthand for the whole class, which includes:

If you're curious how these two medications differ, our guide to tirzepatide vs. semaglutide covers the basics.

None of these medications, brand-name or compounded, is approved for fertility treatment. Reproductive endocrinologists (doctors who specialize in hormones and fertility) have noted the pattern, but the explanation is more nuanced than "GLP-1s make you fertile."

A 2025 study published in PLOS One compared social media posts about GLP-1s and fertility with the published research. Online sentiment was mostly positive and was broadly consistent with findings reported in studies involving women with PCOS. But the researchers found a notable gap: There was a lack of research on how these medications affect fertility in women without PCOS.

‍

How GLP-1 Medications May Affect Fertility

GLP-1 medications may support fertility indirectly through weight loss and improved overall health. Here's a closer look at what that means.

The Weight Loss Connection

Most fertility improvements reported with GLP-1 use appear to come from weight loss and its metabolic effects.

Ovulation depends on the hypothalamic-pituitary-ovarian (HPO) axis, a hormonal communication pathway between your brain and ovaries. Excess weight may interfere with this pathway, and obesity is associated with insulin resistance (when your cells don't respond to insulin as well as they should) and changes in sex hormone levels, both of which may suppress ovulation.

Dr. Jenna McCarthy, a reproductive endocrinologist at IVFMD, explained to Endocrinology Advisor that being significantly over- or underweight "sends a signal to their brains that pregnancy at that moment isn't safe." Other reproductive doctors similarly link the trend to better metabolic health and weight loss, which may help restore ovulation.

As weight loss happens, a woman's cycles may become more regular, and ovulation may return. This may even happen before the individual realizes it, resulting in accidental and surprise pregnancies.

Possible Direct Effects on Reproductive Function

Some early research suggests GLP-1s may influence the reproductive system beyond weight loss. GLP-1 receptors have been found in reproductive tissues, including the ovaries and the endometrium (the lining of the uterus).

Preclinical (animal and lab) studies point to possible effects on luteinizing hormone (which triggers ovulation), ovarian structure, and how receptive the uterine lining is to an embryo. A review in Advances in Clinical and Experimental Medicine also describes reported anti-inflammatory effects in the ovaries and endometrium.

But this research is preliminary and largely based on animal studies. A 2025 review in Acta Obstetricia et Gynecologica Scandinavica notes that effects on the human endometrium remain unclear, and none of the evidence supports GLP-1s as fertility medications.

‍

GLP-1s and PCOS: A Closer Look

Polycystic ovary syndrome (PCOS) is a hormonal condition that affects ovulation and is closely tied to insulin resistance and weight gain. In May 2026, it was officially renamed polyendocrine metabolic ovarian syndrome (PMOS) to better reflect its hormonal and metabolic roots, though both names are still in use.

Since PCOS involves metabolic factors that GLP-1 medications may influence, including insulin resistance and weight, women with PCOS may see the most fertility-related benefit. In the PLOS One analysis, all 52 original PubMed studies on GLP-1 medications in women with PCOS were rated as positive.

Dr. McCarthy (mentioned above) has also observed that some patients with PCOS return for fertility treatment after losing weight on a GLP-1, often with better responses to fertility medications and improved pregnancy rates.

However, there's a flip side. Many women with PCOS have irregular or absent periods. This means that they may not notice when ovulation returns, which can lead to unplanned pregnancies.

If you have PCOS and take a GLP-1, talk with your provider about contraception, even if pregnancy has felt unlikely before. They may also explore other options with you, such as metformin for PCOS. Your treatment plan will ultimately depend on your needs and health history.

‍

GLP-1s and Birth Control: What You Need to Know

If you rely on contraceptive pills, here's what you should know about semaglutide birth control concerns and the more specific tirzepatide contraception guidance.

How GLP-1s Slow Gastric Emptying, and Why That Matters for Oral Contraceptives

GLP-1 medications slow gastric emptying (the speed at which food moves from your stomach into your small intestine, where most absorption happens). This is part of how they help you feel full longer. But it also means oral medications, including birth control pills, may be absorbed differently.

Think of it like a slower conveyor belt. The pill still gets where it's going, but the timing of absorption may change.

Tirzepatide and Oral Contraceptives: The Specific Warning

The Zepbound® prescribing information, like Mounjaro®'s, states that tirzepatide may reduce the effectiveness of oral hormonal contraceptives due to delayed gastric emptying. According to Lilly's medical information, this delay is greatest after the first dose and lessens over time.

For this reason, the labels advise individuals using birth control pills to switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase.

Since the precaution is tied to how tirzepatide affects gastric emptying, ask your provider whether you should follow the same backup-contraception steps if you take compounded tirzepatide. They can advise on what's best in your specific situation.

Interestingly, semaglutide's prescribing information doesn't include this same explicit recommendation, even though semaglutide also slows gastric emptying.

If you are taking tirzepatide (brand-name or compounded) and using oral birth control, talk to your provider before making any changes to your contraception, and check in each time your dose changes.

What Birth Control Options May Be Less Affected

Non-oral methods bypass the digestive system, so they aren't subject to the same absorption concern. These include hormonal or copper IUDs, implants, patches, vaginal rings, and injections, and Eli Lilly notes that hormonal contraceptives not taken by mouth shouldn't be affected.

At the same time, it's still important to discuss it with your prescribing provider regarding your specific situation.

‍

Is It Safe to Be Pregnant While Taking a GLP-1?

If you've just found out you're pregnant while taking a GLP-1, the most important first step is to contact your healthcare provider. They can recommend the next best step for you.

In terms of GLP-1 pregnancy safety, here's what the current research shows:

  • In animal reproduction studies, semaglutide was linked to structural abnormalities and changes in fetal growth, which is why the Wegovy® prescribing information warns of possible fetal harm. Tirzepatide's label notes potential fetal risks based on animal data, too.
  • Human data are limited. However, a 2024 BMJ Open study followed 168 pregnancies with first-trimester GLP-1 exposure and found no evidence of an increased risk of major birth defects or pregnancy loss compared with the comparison groups studied. Yet, the sample was small, so more research is needed.

The clinical consensus is to stop the medication immediately when pregnancy is discovered. This applies to any dose, including a microdose, and to compounded products. In other words: If you become pregnant while taking a GLP-1 medication, at any dose, stop the medication and contact your healthcare provider immediately.

‍

Planning to Get Pregnant? When to Stop Your GLP-1

The recommended time to stop GLP-1s when planning a pregnancy largely depends on how long each medication stays in your body, measured by its half-life (the time it takes for half the drug to leave your system). Here are the basics:

Medication Approximate Half-Life Washout Guidance
Semaglutide (Ozempic®, Wegovy®, compounded semaglutide) About 1 week Wegovy® label: stop at least 2 months before a planned pregnancy
Tirzepatide (Mounjaro®, Zepbound®, compounded tirzepatide) About 5 days No set timeline in U.S. labels; UK regulators advise at least 1 month

In practice, many providers suggest stopping at least 1 to 2 months before trying to conceive, depending on the medication. Your provider can give you a more specific timeline.

A lower or microdosed GLP-1 is still GLP-1 exposure. The washout guidance applies regardless of dose.

Additionally, stopping a GLP-1 may lead to some weight regain, which is another reason to plan your transition with your provider.

After Pregnancy: Restarting a GLP-1

When to restart a GLP-1 after delivery or breastfeeding is a decision that should be made with your provider. Some people restart at a low dose and increase gradually, but the right timing depends on your recovery, whether you're breastfeeding, and your overall health.

Ongoing provider access can make these transitions feel more manageable. With Eden's provider-guided GLP-1 treatment, you can get started with a quick online intake. A licensed provider reviews your health history, goals, and current medications, including your birth control, and determines an appropriate care plan if treatment is appropriate. If prescribed, your medication may be shipped to your door from a licensed pharmacy with free expedited shipping, and you can message your care team 24/7, including about what a dose change means for your birth control. Pricing stays the same at every dose, and no insurance is required.

Start your journey today
Get started with Eden
Trusted by 
127,000+ members globally
Same price at every dose. No long-term contracts.
Start your weight loss journey with Compounded Semaglutide
"I had an incredible experience, and the support that Eden provides is 10/10"
Kerstin
Verified Customer
“I had so many questions in the beginning, and both the doctor and customer support were so patient and thorough.”
Lane L.
Verified Customer
Compounded Semaglutide
₹6,999/month
Non-stimulant weight loss
Improves blood sugar control
Naturally suppresses appetite
Before
Connie before GLP-1 Weight Loss
After
Connie after GLP-1 Weight Loss
Connie is a verified Eden member
Get started
Learn more about this treatment
Disclaimer

Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.

Eden is not a medical provider. Eden connects individuals with independent licensed healthcare providers who independently evaluate each patient to determine whether a prescription treatment program is appropriate. All prescriptions are written at the sole discretion of the licensed provider. Medications are filled by state-licensed pharmacies. Please consult a licensed healthcare provider before making any medical decisions.

Frequently asked questions

Can GLP-1 medications cause pregnancy?

GLP-1 medications aren't fertility drugs, but by supporting weight loss and metabolic health, they may help restore ovulation and improve the chance of conception, sometimes unexpectedly. If you don't want to become pregnant, use effective contraception and talk with your provider about your options.

Does semaglutide affect birth control?

Semaglutide slows gastric emptying, which may theoretically affect pill absorption, though its label lacks tirzepatide's explicit warning. If you're concerned, talk with your provider; non-oral methods aren't affected by this mechanism.

Does tirzepatide make birth control less effective?

It may, which is why the Mounjaro® and Zepbound® labels recommend a non-oral or backup barrier method for 4 weeks after starting and for 4 weeks after each dose increase. If you take compounded tirzepatide, ask your provider whether the same precaution applies before changing your birth control.

Does microdosing a GLP-1 affect birth control?

There's limited research on how low-dose GLP-1 plans affect contraception specifically. The safest approach is to treat every dose increase, even a small one, as a time to check in with your provider about backup contraception, especially with tirzepatide.

What should I do if I get pregnant while on a GLP-1?

Stop the medication and contact your provider right away. Limited human data haven't shown a clear rise in birth defect risk, but GLP-1s aren't recommended during pregnancy at any dose.

Can GLP-1s help with PCOS and fertility?

GLP-1s may support fertility in women with PCOS by improving insulin resistance and weight, which may help restore ovulation. They aren't approved fertility treatments, so work with a reproductive endocrinologist and your prescriber if you're trying to conceive.

When should I stop my GLP-1 (including a microdose) if I want to get pregnant?

The Wegovy® label recommends stopping semaglutide at least 2 months before a planned pregnancy, while U.S. tirzepatide labels don't set a timeline (UK guidance suggests at least 1 month). A lower or microdosed GLP-1 is still exposure to the medication, so the same washout guidance applies regardless of dose. Your provider can determine what's best for you.

‍

References

Dao, K., et al. (2024). Use of GLP1 receptor agonists in early pregnancy and reproductive safety: A multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services. BMJ Open, 14(4), e083550. https://bmjopen.bmj.com/content/14/4/e083550

Eli Lilly and Company. (2026). MOUNJARO® (tirzepatide) injection: Highlights of prescribing information. https://pi.lilly.com/us/mounjaro-uspi.pdf

Eli Lilly and Company. (2026). ZEPBOUND® (tirzepatide) injection: Highlights of prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s042lbl.pdf

Eli Lilly and Company. (n.d.). Can Zepbound® (tirzepatide) be used with oral contraceptives or hormone replacement therapy? Lilly Medical. https://medical.lilly.com/us/products/answers/can-zepbound-tirzepatide-be-used-with-oral-contraceptives-or-hormone-replacement-therapy-211019

Endocrinology Advisor. (2026). The Ozempic baby boom: How do GLP-1s affect fertility? https://www.endocrinologyadvisor.com/features/glp-1-and-fertility/

Medicines and Healthcare products Regulatory Agency. (2025). GLP-1 medicines for weight loss and diabetes: What you need to know. GOV.UK. https://www.gov.uk/government/publications/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know

Merhi, Z., Karekar, M., & Mouanness, M. (2025). GLP-1 receptor agonist for weight loss and fertility: Social media and online perception versus evidence-based medicine. PLOS ONE. https://pmc.ncbi.nlm.nih.gov/articles/PMC12221084/

Novo Nordisk. OZEMPIC® (semaglutide) injection: Full prescribing information. https://www.novo-pi.com/ozempic.pdf

Novo Nordisk Inc. (2026). WEGOVY® (semaglutide) injection and tablets: Highlights of prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/218316s007lbl.pdf

Papaetis, G. S., & Kyriacou, A. (2022). GLP-1 receptor agonists, polycystic ovary syndrome and reproductive dysfunction: Current research and future horizons. Advances in Clinical and Experimental Medicine, 31(11), 1265. https://advances.umw.edu.pl/pdf/2022/31/11/1265.pdf

Sola-Leyva, A., Pathare, A. D. S., Apostolov, A., Aleksejeva, E., Kask, K., Tammiste, T., Ruiz-Durán, S., Risal, S., Acharya, G., & Salumets, A. (2025). The hidden impact of GLP-1 receptor agonists on endometrial receptivity and implantation. Acta Obstetricia et Gynecologica Scandinavica, 104(2), 258–266. https://pmc.ncbi.nlm.nih.gov/articles/PMC11782050/

White, L. (2026, June 1). PCOS gets a new name: Polyendocrine metabolic ovarian syndrome (PMOS). American Academy of Family Physicians. https://www.aafp.org/afp/afp-community-blog/pcos-gets-a-new-name-polyendocrine-metabolic-ovarian-syndrome-pmos